$13.12
-0.22-1.65%
Últ. Act.: Oct 28, 8:43 AM

Eloxx Pharma (ELOX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | $-1.97 | $-1.54 | $-2.55 |
| Actual | $-0.66 | $-1.31 | $-1.96 | $-2.88 |
| Surprise | — | +33.5% | -27.3% | -12.9% |
| Revenue | ||||
| Estimate | — | — | — | $700000 |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | -100.0% |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 13, 2023 | $-1.31 | $-1.97 | 33.5 % |
| Q2 | Aug 14, 2023 | $-1.96 | $-1.54 | -27.3 % |
| Q1 | May 15, 2023 | $-2.88 | $-2.55 | -12.9 % |
| Q4 | Apr 3, 2023 | $-2.92 | $-2.97 | 1.68 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q1 | May 15, 2023 | $0 | $700.00K | -100.0 % |
| Q2 | Aug 15, 2022 | $0 | $2.33M | -100.0 % |
| Q1 | May 10, 2022 | $0 | $3.50M | -100.0 % |